In a concerning health development, Cyrus S. Poonawalla, the Managing Director of the renowned Serum Institute of India, suffered a mild cardiac arrest on November 16. Prompt medical attention ensued as he was admitted to Ruby Hall on the early morning of November 17. Under the expert supervision of Dr. Purvez Grant, Dr. Makle, and Dr. Abhijeet Khardekar, Poonawalla underwent a successful angioplasty. The medical team has reported that he is now in stable condition and recovering rapidly.
Swift Response to Health Crisis
The health incident unfolded when Cyrus Poonawalla, an influential figure in the pharmaceutical and vaccine manufacturing sector, experienced a mild cardiac arrest. Given the urgency of the situation, he was quickly admitted to Ruby Hall for immediate medical intervention.
Successful Angioplasty Procedure
To address the cardiac concerns, Poonawalla underwent an angioplasty, a medical procedure aimed at widening and unblocking the coronary arteries. The procedure was conducted by a team of experienced cardiologists, including Dr. Purvez Grant, Dr. Makle, and Dr. Abhijeet Khardekar. The medical experts worked diligently to ensure a successful intervention.
Stable Recovery and Positive Outlook
Following the angioplasty, Cyrus Poonawalla is reported to be in stable condition and is on the path to recovery. The medical team, led by Dr. Purvez Grant, has expressed satisfaction with the progress made during the postoperative phase. Ali Daruwala, an advisor at Ruby Hall clinic, provided assurance about Poonawalla’s swift recovery.
